bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.03.25.645194

Modulation of gut microbiota through in vitro exposure to a traditional fermented food in the context of pathogen invasion

Abstract

The gut microbiota consisting of bacteria, fungi, archea, and viruses and plays a role as a barrier against pathogen invasion to promote intestinal health and preventing organismal infections. This study examined the potential protective properties of Mabisi, a widely consumed traditional fermented dairy product in Zambia, against pathogen invasion in the gut. Using the in-vitro static INFOGEST model, we challenged the gut microbiota from a pooled stool sample pf six Zambian children) and previously exposed to Mabisi by adding model pathogens. We hypothesized that pathogen invasion is suppressed in in-vitro gut microbiota treated with Mabisi due to its ability to modulate the gut microbiota composition. Our microbiota challenge treatments were Mabisi, fructooligosaccharides (FOS) as a positive control, sterile water as a negative control, and with and without pathogens. Out of the two strains of pathogens added to the gut microbiota, Escherichia coli established in FOS treated gut microbiota, however not in Mabisi and sterile water treatments. Furthermore, we show that Mabisi modulated gut microbiota by increasing Pediococcus, a commensal bacteria and increased production of short chain fatty acids including acetate, propionate, lactate, isobutyrate, formate, and succinate in Mabisi treated gut microbiota compared to both FOS and sterile water treated gut microbiota. This study contributes to evidence of the beneficial role of fermented foods such as Mabisi through the prevention of pathogen invasion of the gut microbiota in children. ImportanceThis study provides evidence supporting the protective role of Mabisi, a traditional fermented dairy product, in preventing pathogen invasion in the gut microbiota of children. By using an in-vitro approach, we demonstrate that Mabisi treatment suppresses the establishment of Escherichia coli, a key pathogen, unlike fructooligosaccharides (FOS), a well-known prebiotic. Additionally, Mabisi modulates gut microbiota composition by increasing beneficial bacteria such as Pediococcus and enhancing short-chain fatty acid (SCFA) production, which is essential for gut health. These findings highlight the potential of traditional fermented foods as affordable, accessible dietary interventions for improving gut health and preventing infections, particularly in low-resource settings like Zambia.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Nyati, M., van Mastrigt, O., Talsma, E. F., Shindano, J., ZWAAN, B., Schoustra, S.. 2025-03-26. Modulation of gut microbiota through in vitro exposure to a traditional fermented food in the context of pathogen invasion. https://doi.org/10.1101/2025.03.25.645194

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A population-scale landscape of the subgingival microbiome reveals divergent routes to periodontal dysbiosis

Periodontitis is an archetypical mucosal inflammatory disease in which microbiome dysbiosis at the tooth-epithelial interface interacts with host genetic and behavioral risk factors to drive immune-mediated tissue destruction. Although subgingival microbiome compositional shifts are thought to parallel disease severity, microbiome variation at the population-level and its relationship to periodontal clinical phenotypes and disease-modifying factors remain poorly defined. Here, we use unsupervised manifold learning to map the compositional landscape of the subgingival microbiome in 1,355 adults spanning periodontal health to severe periodontitis. We identified eight latent microbiome states organized along a branching continuum from eubiosis to dysbiosis. An intermediate microbial configuration marked ecological destabilization and bifurcation into two distinct periodontitis-associated dysbiotic trajectories, distinguished by links to gingival inflammation and smoking. Although the microbiome trajectories broadly tracked periodontal destruction, a minority of individuals showed discordant microbiome-clinical phenotypes, with some individuals with periodontitis retaining otherwise eubiotic microbiomes enriched for low-abundance pathobionts, while some cases of health or mild disease had highly dysbiotic communities, suggesting distinct host susceptibility. Together, these findings define a population-scale ecological landscape of the subgingival microbiome, reveal divergent trajectories to periodontal dysbiosis, and highlight heterogeneity in the relationship between microbial community structure and clinical disease expression.

microbiology↗

Beta-lactam enhancement against methicillin-resistant Staphylococcus aureus by cell wall blockade is autolysis-dependent: a butyrolactone derivative as case in point

Methicillin-resistant Staphylococcus aureus (MRSA) is non-susceptible to beta-lactams. Blockade of cell wall biosynthesis is a potential target for beta-lactam enhancement but requires further investigation. A butyrolactone derivative enhanced beta-lactams against MRSA strains by reducing the availability of D-Ala-D-Ala. Unlike D-cycloserine, it did not inhibit D-Ala-D-Ala ligase (Ddl). Nor did it show an additive or synergistic effect when combined with cycloserine, indicating a unique mechanism for blocking cell wall precursor production that does not involve the traditional Lipid II pathway. Notably, beta-lactam potentiation by our chemical or D-cycloserine was highly dependent on the intrinsic autolytic ability of the tested MRSA strains. Strains that resisted lysis upon Triton X-100 exposure showed a minimal increase in beta-lactam susceptibility, whereas highly autolytic strains showed significant changes in their beta-lactam MICs. We have thus identified autolytic ability as the Achilles Heel in the strategy of targeting cell wall biosynthesis for beta-lactam potentiation.

microbiology↗

Rapid and largely reversible shifts in the canine fecal metabolome during dietary change

Diet can rapidly change the fecal metabolome, but less is known about recovery after the original diet is restored. We used untargeted UPLC-MS metabolomics to analyze 72 fecal samples from nine Pumi dogs during an owner-managed switch from dry food to raw food and back to dry food. Diet phase accounted for a large proportion of variation in both ionization modes. More than 13,000 LC-MS features changed at the first sampling point after the switch to raw food, with a similarly large response after return to dry food. Among features significant in both comparisons, more than 99% changed in opposite directions. At the final sampling point, no positive-mode (ESI+) features and only 13 negative-mode (ESI-) features differed from the second dry-food baseline under the same threshold. BARF-associated patterns persisted in analyses excluding individual dogs and in pedigree-adjusted candidate models, although individual feature effects depended on normalization. Putative metabolites from several biochemical classes differed in their response and recovery. The fecal metabolome therefore changed rapidly and returned largely toward baseline, with differences among dogs.

microbiology↗